当前位置:首页 > 新闻中心 > 科研动态

人工器官研究所公开讲座——世说心语 第6讲

发布日期:2018-06-08

报告题目:血液接触医疗设备发展面临的挑战与机遇
Challenges and Opportunities in Development of Blood Contacting Medical Devices
 
报告人:吴忠俊 教授
时间:6月8日(周五) 下午4:00
地点:苏州大学工科楼1207会议室 
 
讲座内容简述
心血管疾病(CVD)是发达国家的主要死亡原因。血液接触医疗设备已被普遍用于治疗各种形式的心血管/心肺疾病,或取代患病的人体器官,提高了许多救治无望患者的生存率。虽然目前的设备相比于以前更具有生物相容性,但它们仍然会导致血液损伤,如溶血、血小板活化、血栓形成和出血,这可能导致严重的临床事件。在本文中,将介绍这些设备从概念到临床实践的发展,讨论与血液接触医疗设备相关的基本技术问题及发展面临的挑战和机遇。
 
Cardiovascular disease (CVD) is the leading cause of death in the developed countries. Blood contacting medical devices have been commonly used to treat various forms of cardiovascular/cardiopulmonary diseases or to replace diseased human organs, enhancing survival for many patients with otherwise hopeless medical conditions. Although current devices are more biocompatible than their forerunners, they still cause blood damage, such as hemolysis, platelet activation, thrombosis and bleeding, which may result in serious clinical events. In this talk, development of these devices from concept to clinical practice will be presented. The fundamental technical problems associated with blood contacting medical devices will be discussed. Challenges and opportunities in development of these devices will also be discussed.  
 
报告人简介
吴博士是Peter G Angelos著名的外科教授和马里兰大学医学院人工器官实验室主任。他于1996从迈阿密大学获得生物医学工程博士学位,1989年在中国科学院获得硕士学位,1986在清华大学获得学士学位。他也是马里兰大学生物工程学院的教授。
吴博士从事心血管/肺疾病的基础研究和应用研究,以及与人工器官发展相关的基本技术问题。吴博士发表了超过100篇同行评议的期刊文章、2本书、24篇同行评审的会议论文和150篇会议摘要。授权美国专利三项,申请专利六项。他曾是多种专业和科学委员会的成员,包括美国FDA技术评审委员会,NIH研究部门和美国国防部特别重点小组。吴博士是ASAIO、BMES和ASME的成员。吴博士在ASAIO期刊和心血管工程和技术的编辑委员会工作。他是美国医学与生物工程研究所(AIMBE)的研究员。
Dr. Wu is the Peter G Angelos Distinguished Professor in Entrepreneurial Surgical Sciences and Director of the Artificial Organs Laboratory at the University of Maryland School of Medicine. He received his Ph.D. in Biomedical Engineering from the University of Miami in 1996, his MSE from the Chinese Academy of Sciences, China in 1989 and his BSE from Tsinghua University, China in 1986. He is also Research Professor of Bioengineering at the University of Maryland College Park. 
Dr. Wu is engaged in the basic and applied research of cardiovascular/pulmonary diseases and fundamental technical problems associated with artificial organ development. Dr. Wu has published over 100 peer-reviewed journal articles, 2 book chapters, 24 peer-reviewed conference proceeding papers, and 150 conference abstracts. He holds three issued US patents and have six filed patent applications. He has served as a member of various professional and scientific committees, including the U.S. FDA Technical Review Committee, NIH Study Sections and US DoD special emphasis panels. Dr. Wu is a member of ASAIO, BMES, and ASME.  Dr. Wu serves on the Editorial Board of ASAIO Journal and Cardiovascular Engineering and Technology. He is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).
 
(机电工程学院生物制造研究中心)